{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-270020","form_type":"8-K","ticker":"LXRX","cik":"0001062822","company_name":"LEXICON PHARMACEUTICALS, INC.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.695832+00:00","generated_at":"2026-05-16T23:20:21.532317+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Lexicon files prospectus supplement for $75M ATM equity facility; no sales to date","bullets":["Filed prospectus supplement for at-the-market offering of up to $75M of common stock through Jefferies LLC.","No shares have been sold under the facility as of November 6, 2025.","Legal opinion from Vinson & Elkins L.L.P. on share validity filed as Exhibit 5.1.","Facility originally established under Open Market Sale Agreement dated December 29, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-270020","json":"https://secwatch.observer/filing/0001193125-25-270020.json","markdown":"https://secwatch.observer/filing/0001193125-25-270020.md","text":"https://secwatch.observer/filing/0001193125-25-270020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1062822/000119312525270020/0001193125-25-270020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1062822/000119312525270020/d37543d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:20:21.532317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}